Gene therapy clinical trials are increasingly complex and challenging. Understanding two of the biggest hurdles: patient recruitment and manufacturing costs, can help companies avoid potential pitfalls. Patient Recruitment Patient recruitment for genetic therapy product clinical trials presents a significant problem. Current gene therapy products often target rare diseases or specific genetic risk…

KCR Consultant, Zaneta Szkarlat, PhD and KCR Principal Consultant, Dave Li MD, PhD. Selecting appropriate sites is one of the most crucial factors for determining successful completion of a clinical trial. It is important to ensure that potential trial sites have the capability to meet the protocol requirements and the…

Medical Director, Piotr Piotrowski has spent nearly nine years with KCR. He has decided to pursue his career further as a researcher, but before he leaves, we got the opportunity to sit down with Piotr for an interview about his experiences and to reflect on the growth, challenges and relationships…

FSP, or Functional Service Provision model, provides specific functional services to support clinical research activities and optimize clinical development. ​ At KCR, FSP solution offers a wide range of tailored functional services, from comprehensive clinical monitoring to pharmacovigilance and data management). …

Doug Bain, KCR Chief Technology Officer Consider this scenario; A CRO performs a bid defense. During this, they present screenshots of colorful dashboards with pie charts, trend lines (going up), drill downs and KPI’s. Wonderful! The client is impressed, but over time, the client’s initial interest leads to disappointment because…

The Annual ASCO meeting was held from June 2–6, 2023, at McCormick Place in Chicago with approximately 46,000 professionals and scientists and others from around the globe participating online or in-person. …

Agnieszka Tremblay, KCR Director of Clinical Monitoring, North America KCR had another great experience attending MassBio’s annual “State of Possible” conference last week. It was exciting to hear local leaders speak about the future of life science innovation, the challenges the industry currently faces, and new paths toward success. There…

Dr. Anna Baran, KCR Chief Medical Officer Last week’s press release from the Health and Food Safety Department of the European Commission reignites hope for a new path towards regulating the European pharmaceutical market but also to addressing vital public health challenges. Some of the key messages from the release…

Why do we need patient-centric solutions in clinical trials? We understand the multitude of challenges that Sponsors face throughout a clinical trial, and we have comprehensive and innovative solutions to address them. …